Peptic ulcer disease (PUD) is a condition characterised by open sores in the lining of the stomach, or duodenum, or lower oesophagus. It is commonly caused by Helicobacter pylori infection or long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs). Symptoms include burning or gnawing stomach pain, and treatment typically involves antibiotics, acid-reducing medications, and lifestyle changes.
Last updated on : 30 Apr, 2026
Read time : 14 mins

Peptic ulcer disease (PUD) is a common gastrointestinal disorder that affects millions of people worldwide. It occurs when the protective mucus layer of the stomach or duodenum is compromised, allowing the digestive acids to erode the lining and cause ulcers. In this article, we will explore the causes, symptoms, diagnosis, and treatment of peptic ulcers to provide a comprehensive overview of this prevalent gastrointestinal condition.
A peptic ulcer is an open sore that develops on the inner lining of the stomach (gastric ulcer) or the upper part of the small intestine, known as the duodenum (duodenal ulcer). These ulcers form when the protective mucus layer that shields the stomach and duodenum from digestive acids is weakened or breaks down, allowing the acids to eat away at the underlying tissue. Peptic ulcers can cause significant discomfort and may lead to complications if left untreated, making early diagnosis and appropriate treatment crucial.
| Category | Details |
| Also Referred to as | Stomach ulcer, gastric ulcer, duodenal ulcer, peptic ulcer disease |
| Commonly Occurs In | Adults, especially older adults, and those with H. pylori infection or NSAID use |
| Affected Organ | Stomach, duodenum (first part of the small intestine) |
| Type | Gastric ulcer (in the stomach), Duodenal ulcer (in the duodenum) |
| Common Signs | Burning stomach pain, nausea, bloating, belching, vomiting, and blood in the stool |
| Consulting Specialist | Gastroenterologist, General surgeon |
| Treatment Procedures | Medicines to reduce stomach acid, antibiotics for H. pylori, lifestyle changes, and surgery if necessary |
| Managed By | Antibiotics (Amoxicillin, Clarithromycin, Metronidazole & Tetracycline), Proton pump inhibitors (Omeprazole, Pantoprazole & Rabeprazole), H2-receptor antagonists (Famotidine & Nizatidine), Antacids, Surgery (Vagotomy, Ant |
| Mimicking Condition | Heartburn, indigestion, gastro-esophageal reflux disease (GERD) |
The various types of peptic ulcers include:
Identifying the specific type of peptic ulcer is essential for determining the most effective treatment approach and managing potential complications.
The early signs of a peptic ulcer include:
The symptoms of peptic ulcers can vary among individuals, but they commonly include the following:

Peptic ulcer disease does not have a formal clinical staging system. Ulcers may be described as acute (newly formed) or chronic (long-standing or recurrent), but this classification is descriptive rather than a staged progression of disease. Chronic ulcers are more often associated with persistent H. pylori infection or ongoing NSAID use.
The most common causes of peptic ulcers include:

Several factors can increase the likelihood of developing these ulcers, including:
Certain populations are more at risk for developing peptic ulcers, including:
Understanding personal risk helps with the prevention and early detection of peptic ulcers through lifestyle changes and regular check-ups.
Peptic ulcers can lead to several serious complications if not properly managed. Some of the potential complications include:
Preventing peptic ulcers involves addressing common causes and risk factors. Some of the preventative measures include:
Diagnosing peptic ulcers involves a combination of medical history, physical examination, and diagnostic tests. The most common tests used to diagnose peptic ulcers include:
The management of peptic ulcer disease involves several treatment options customised to the specific cause and complications of the ulcer. The treatment options include:
Peptic ulcers caused by Helicobacter pylori (H. pylori) infection require a targeted treatment approach to eradicate the bacteria and promote ulcer healing. In many regions, bismuth-based quadruple therapy is recommended as first-line treatment because of increasing clarithromycin resistance. Triple therapy may still be used where clarithromycin resistance rates are low (ACG, 2022). The prescribed antibiotics include Amoxicillin, Clarithromycin, Metronidazole, Tinidazole, and Tetracycline, which work synergistically to eliminate H. pylori. In some cases, quadruple therapy, which includes a bismuth-containing compound, may be recommended for treatment-resistant infections.
Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) can damage the stomach lining, leading to ulcers. The first step in treatment is discontinuing NSAID use whenever possible. If the patient requires continued NSAID therapy for pain or inflammation management, PPIs such as Pantoprazole and Omeprazole are prescribed to reduce gastric acid secretion and prevent further mucosal damage. Additionally, alternative medications like COX-2 inhibitors may be considered, as they pose a lower risk of gastric ulcer formation (NICE, 2023).
For patients who fail initial H. pylori treatment, sequential or quadruple therapy is recommended. Quadruple therapy typically includes a PPI, two antibiotics, and a bismuth compound, enhancing bacterial eradication rates. Non-bismuth-based sequential therapy follows a stepwise approach, first administering a PPI and amoxicillin, followed by a PPI combined with clarithromycin and metronidazole or tinidazole. These alternative regimens increase effectiveness, especially in cases where bacterial resistance to standard antibiotics is a concern.
Bleeding peptic ulcers are a medical emergency requiring immediate intervention. Initial treatment involves intravenous (IV) PPI therapy, which stabilises the clot and reduces gastric acid to prevent further bleeding. Endoscopic therapy is the preferred approach to achieve hemostasis, using techniques such as thermal coagulation, injection therapy, or hemoclips to control bleeding at the ulcer site. If endoscopic treatment is unsuccessful, angiographic embolisation or surgical intervention may be required to manage persistent haemorrhage.
Perforated ulcers, where the ulcer erodes completely through the stomach or duodenal wall, can lead to life-threatening peritonitis. Stenosis, or narrowing of the gastric outlet, occurs due to chronic ulceration and scarring. These conditions often require surgical intervention, particularly if perforation leads to peritoneal contamination or if stenosis causes severe obstruction. Surgery may involve simple closure of the perforation, gastric resection, or bypass procedures, depending on the severity. In mild cases, conservative management with IV PPIs, nasogastric decompression, and close monitoring may be attempted.
To prevent ulcer recurrence, especially in high-risk patients, long-term PPI therapy is recommended. Patients who cannot tolerate PPIs or require alternative options may use histamine 2-receptor antagonists H2RAs such as Famotidine or Nizatidine (Ranitidine is no longer recommended due to withdrawal from many markets), which work by inhibiting histamine-induced acid secretion. Maintenance therapy is particularly crucial for individuals who have a history of recurrent ulcers, require long-term NSAID or aspirin therapy, or have persistent H. pylori infections.
For immediate symptom relief and gastric mucosal protection, additional medications are used alongside primary treatment strategies. Antacids such as Sodium Bicarbonate, Magnesium Hydroxide, Aluminium Hydroxide, and Magaldrate neutralise stomach acid and provide rapid relief from ulcer-related pain and discomfort. Ulcer protectives like Sucralfate and Colloidal Bismuth form a protective barrier over the ulcer, promoting healing and preventing further irritation from gastric acids. Anticholinergics, including Pirenzepine and Oxyphenonium, help reduce acid secretion by blocking vagal stimulation, thereby aiding ulcer healing. These medications complement primary treatment approaches and enhance overall patient recovery.
It is essential to seek medical attention if you experience symptoms of a peptic ulcer, such as persistent stomach pain, nausea, vomiting, or dark stools. If left untreated, peptic ulcers can lead to serious complications like bleeding, perforation, or obstruction. You should also consult a doctor if you have a history of peptic ulcers and are taking NSAIDs or low-dose aspirin, as these medications can increase the risk of ulcer recurrence.
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.23.3
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners

